Ameritas Advisory Services’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Ameritas Advisory Services's RPRX Position: Q2 2026 in Review
Ameritas Advisory Services reduced its Royalty Pharma (RPRX) stake by 98% in Q2 2026, selling an estimated $253K and leaving 99 shares worth $5.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1555.
Ameritas Advisory Services first reported a position in RPRX in Q1 2023 and has held it in 5 quarters since. The position peaked at $238K in Q1 2026. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Ameritas Advisory Services held 99 shares of Royalty Pharma worth $5.55K as of Q2 2026.
- Ameritas Advisory Services sold 4,866 Royalty Pharma shares in Q2 2026, an estimated $253K.
- Royalty Pharma made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1555 holding.
- Ameritas Advisory Services first reported a position in Royalty Pharma in Q1 2023 and has held it in 5 quarters since.
- Ameritas Advisory Services's Royalty Pharma position peaked at $238K in Q1 2026.
- 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.